Skip to content

Clinical trials

Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Country / region: France Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20181
20192
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines1
Enterome1
Genmab1
Gilead Sciences1
IGM Biosciences, Inc.1
Loxo Oncology, Inc.1
Lymphoma Study Association1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular6
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma2
Lymphoma, B-Cell2
Waldenstrom Macroglobulinemia2
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.